Avista Healthcare
NEW YORK, Jan. 19, 2021 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, last week completed its previously announced acquisition of Solmetex, the industry’s leading provider of amalgam separators and other waste compliance products to the U.S. and Canadian dental industries. Terms of the transaction were not disclosed. For over […]
NEW YORK, Jan. 12, 2021 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading New York-based private equity firm with over $6 billion invested in more than 35 healthcare businesses globally, today announced a strategic partnership with Capital Constellation (“Constellation”). Constellation, a group of premier global institutional investors who provide catalytic investment capital and expertise to growing investment management platforms, is managed by […]
NEW YORK, Dec. 17, 2020 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that is has signed a definitive agreement to acquire Solmetex (“Solmetex” or “the Company”), the industry’s leading provider of amalgam separators and other waste compliance products to the U.S. and Canadian dental industries. Terms of the […]
New York, NY – October 15, 2020 – Arcadia Consumer Healthcare, Inc., a recognized leader in the consumer healthcare market for over-the-counter medicines, today announced that it has completed the acquisition of NATURELO®, a premium brand of vitamins, minerals, and supplements (“VMS”) derived from ‘whole food’ ingredients. Financial terms of the transaction were not disclosed. Arcadia Consumer […]
SAN DIEGO, Calif., – September 22, 2020 – COVID-19 has impacted diagnostic volumes, mix and reimbursement for a variety of diagnostic providers. As the nation transitions into fall, new challenges will arise for the laboratory industry as students go back to school and flu season hits its peak. XIFIN CEO Lâle White and Kyle Fetter, […]
OSAKA, Japan and BRIDGEWATER, N.J., July 28, 2020 (GLOBE NEWSWIRE) — Santen Pharmaceutical Co., Ltd (hereinafter, Santen) and RVL Pharmaceuticals, Inc., a subsidiary of Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (hereinafter, Osmotica), announced today an exclusive license agreement covering the development, registration, and commercialization rights in Japan, China, and other Asian countries as well as EMEA countries to RVL-1201, oxymetazoline hydrochloride ophthalmic solution 0.1%, which […]
Bridgewater, NJ, July 14, 2020 – Cosette Pharmaceuticals, Inc. (“Cosette” or the “Company”), a privately held specialty generic pharmaceutical company primarily focused on extended topical and suppository products, announced today the appointment of Apurva Saraf as President and Chief Executive Officer. “We are very pleased to welcome Apurva to the Cosette team. His deep knowledge of the […]
NEW YORK, July 8, 2020 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced the appointments of Steve Schiess and William E. Klitgaard to the firm’s operating executive team. Mr. Schiess and Mr. Klitgaard are accomplished leaders who bring decades of experience in the healthcare industry, having built strong, capable teams that achieved operational […]
YARDLEY, Pa., June 30, 2020 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced initiation of development of a new product candidate, OPN-019. OPN-019 will combine the Company’s proprietary nasal Exhalation Delivery System (EDS) technology with an antiseptic that has been recently shown in vitro to kill […]
New York, NY – June 1, 2020 – Avista Capital Partners (“Avista”), a leading healthcare private equity firm, along with VHC Investco and company management, today announced the acquisition of Vision Healthcare NV (“Vision”), one of Europe’s fastest-growing omni-channel and direct-to-consumer healthcare companies. Avista and VHC Investco/Management will each hold a 50% ownership interest in […]
NEW YORK, March 20, 2020 /PRNewswire/ — Arcadia Consumer Healthcare, Inc., (formerly Kramer Laboratories, Inc.) a recognized leader in the consumer healthcare industry, today announced that is has completed the acquisition of the U.S. rights to the Kaopectate® brand from Sanofi. “The addition of Kaopectate® to our product portfolio represents a perfect opportunity to carry on Arcadia’s tradition of providing […]
FDA revokes Indivior PLC’s orphan designation for opioid use disorder (OUD)* and prevents an additional five-year block of other monthly buprenorphine depot products for OUD Plymouth Meeting, Pa. – November 7, 2019 – Braeburn Inc. is pleased to confirm that it will seek, and is eligible for, marketing approval for BRIXADI™ (buprenorphine) weekly and monthly extended-release […]